chr9-99847497-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_006981.4(NR4A3):​c.1515G>C​(p.Gln505His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

NR4A3
NM_006981.4 missense

Scores

12
5
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.81
Variant links:
Genes affected
NR4A3 (HGNC:7982): (nuclear receptor subfamily 4 group A member 3) This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. The encoded protein may act as a transcriptional activator. The protein can efficiently bind the NGFI-B Response Element (NBRE). Three different versions of extraskeletal myxoid chondrosarcomas (EMCs) are the result of reciprocal translocations between this gene and other genes. The translocation breakpoints are associated with Nuclear Receptor Subfamily 4, Group A, Member 3 (on chromosome 9) and either Ewing Sarcome Breakpoint Region 1 (on chromosome 22), RNA Polymerase II, TATA Box-Binding Protein-Associated Factor, 68-KD (on chromosome 17), or Transcription factor 12 (on chromosome 15). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
STX17-DT (HGNC:51174): (STX17 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.886

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NR4A3NM_006981.4 linkuse as main transcriptc.1515G>C p.Gln505His missense_variant 7/8 ENST00000395097.7
NR4A3NM_173200.3 linkuse as main transcriptc.1548G>C p.Gln516His missense_variant 8/9
NR4A3XM_017015162.2 linkuse as main transcriptc.1515G>C p.Gln505His missense_variant 8/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NR4A3ENST00000395097.7 linkuse as main transcriptc.1515G>C p.Gln505His missense_variant 7/81 NM_006981.4 P1Q92570-1
STX17-DTENST00000655615.1 linkuse as main transcriptn.179-8422C>G intron_variant, non_coding_transcript_variant
NR4A3ENST00000330847.1 linkuse as main transcriptc.1548G>C p.Gln516His missense_variant 6/75 Q92570-3
NR4A3ENST00000618101.4 linkuse as main transcriptc.1548G>C p.Gln516His missense_variant 8/95 Q92570-3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 15, 2024The c.1548G>C (p.Q516H) alteration is located in exon 8 (coding exon 6) of the NR4A3 gene. This alteration results from a G to C substitution at nucleotide position 1548, causing the glutamine (Q) at amino acid position 516 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.51
D
BayesDel_noAF
Pathogenic
0.50
CADD
Pathogenic
30
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.91
D;.;.
Eigen
Pathogenic
0.99
Eigen_PC
Pathogenic
0.96
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D;D;.
M_CAP
Benign
0.070
D
MetaRNN
Pathogenic
0.89
D;D;D
MetaSVM
Uncertain
0.63
D
MutationAssessor
Uncertain
2.6
M;.;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.75
T
PROVEAN
Pathogenic
-4.7
D;.;D
REVEL
Pathogenic
0.72
Sift
Pathogenic
0.0
D;.;D
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
1.0
D;D;D
Vest4
0.81
MutPred
0.76
Gain of catalytic residue at Q505 (P = 0.1727);.;.;
MVP
0.96
ClinPred
1.0
D
GERP RS
6.2
Varity_R
0.73
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr9-102609779; API